|
Post by radgray68 on Apr 26, 2023 16:35:50 GMT -5
“The actions and inactions of FINRA and its members in allowing these liabilities to persist and be substituted with liabilities for different securities in a different company, all while leaving shareholders with counterfeit shares, is unacceptable.”
That answered one of the questions I had about Regulation SHO. It says that if you have a Failure To Deliver (FTD) you eventually have to close out the position (which I assume is mostly complied with voluntarily and also mostly unenforced when it's not) and that closing out the position must be done with shares of "like kind and value". And I always wondered, what the heck does "like kind and value" mean? Now I know. It means whatever the market maker (and apparently FINRA) want it to mean.
I didn't realize FINRA was a self-regulation not-for-profit setup by the financial industry (to avoid additional government oversight). This is common. There are numerous examples within multiple regulated industries of using industry associations to act as a buffer between the regulators and the regulated. If it ever worked well with FINRA, that appears to have broken down. I'm shocked (he said sarcastically as possible).
ADMINISTRATIVE "Law"/regulation takes away representative government and Constitutional protections in regards to the legal "system". Kinda like the American Bar Association. A 'Voluntary" body. Basically, the sharks need to say they have a monitor so... we put the hammerheads in charge. What a racket?
|
|
|
Post by harryx1 on May 11, 2023 12:02:32 GMT -5
|
|
|
Post by prcgorman2 on May 16, 2023 12:08:57 GMT -5
Who wants to bet that greater than 50% of today's volume is shorts piling on top of negative market sentiment?
|
|
|
Post by mymann on May 16, 2023 12:28:18 GMT -5
Harvesting preset sells order. Sp goes up and buy orders comes in with preset sells order to prevent loss. Up one day and down the next day. No breaking news, just slow growth. Crooks always win.
|
|
|
Post by prcgorman2 on May 17, 2023 6:19:10 GMT -5
prcgorman2 Avatar May 16, 2023 12:08:57 GMT -5 prcgorman2 said: Who wants to bet that greater than 50% of today's volume is shorts piling on top of negative market sentiment? Harvesting preset sells order. Sp goes up and buy orders comes in with preset sells order to prevent loss. Up one day and down the next day. No breaking news, just slow growth. Crooks always win. If only. Try 76%. fintel.io/ss/us/mnkd
|
|
|
Post by markado on May 17, 2023 19:13:03 GMT -5
Saw on stocktwits someone questioning the "rational case," for shorting MNKD. Then they postulated many elements of the bull case. Absent a rational case, consider the irrational - meaning, the shorts are (anti) competitively motivated, corporately funded, not profit driven, therefore willing to lose 100% of their investment, because they're not playing with their own money, and the goal is not profit but delay and destruction (of value). Just a hypothesis.
|
|
|
Post by agedhippie on May 18, 2023 14:51:54 GMT -5
Saw on stocktwits someone questioning the "rational case," for shorting MNKD. Then they postulated many elements of the bull case. Absent a rational case, consider the irrational - meaning, the shorts are (anti) competitively motivated, corporately funded, not profit driven, therefore willing to lose 100% of their investment, because they're not playing with their own money, and the goal is not profit but delay and destruction (of value). Just a hypothesis. An excellent example of why I never read stocktwits.
|
|
|
Post by radgray68 on May 18, 2023 15:14:38 GMT -5
Saw on stocktwits someone questioning the "rational case," for shorting MNKD. Then they postulated many elements of the bull case. Absent a rational case, consider the irrational - meaning, the shorts are (anti) competitively motivated, corporately funded, not profit driven, therefore willing to lose 100% of their investment, because they're not playing with their own money, and the goal is not profit but delay and destruction (of value). Just a hypothesis. Those $10 Billion insulin behemoths stand to lose a billion a year in market share to us so what’s to stop them spending a hundred mil over the years tossing shares back and forth between houses to stall or kill us? It’s not outrageous to consider.
|
|
|
Post by agedhippie on May 18, 2023 16:18:07 GMT -5
Saw on stocktwits someone questioning the "rational case," for shorting MNKD. Then they postulated many elements of the bull case. Absent a rational case, consider the irrational - meaning, the shorts are (anti) competitively motivated, corporately funded, not profit driven, therefore willing to lose 100% of their investment, because they're not playing with their own money, and the goal is not profit but delay and destruction (of value). Just a hypothesis. Those $10 Billion insulin behemoths stand to lose a billion a year in market share to us so what’s to stop them spending a hundred mil over the years tossing shares back and forth between houses to stall or kill us? It’s not outrageous to consider. I seriously doubt they see Afrezza as a threat. Last month Afrezza bought in $7.94 Million, Lilly and Novo Nordisk bought in $1.1 Billion on just their old gen RAA insulins. Right now, eight years after launch, Afrezza sells less than the monthly sales fluctuation of either of those two. If you are a big pharma you don't mess with a competitor's stock, that's illegal and leads to bad things for the aggressor. No, you do what UTHR is doing to LQDA - you tie your competitor up in court with worthless suits because that buys you time to have a clear run at the market, this is legal and far more effective. You will know that the big pharmas see Mannkind as a threat when they start filing lawsuits.
|
|
|
Post by sayhey24 on May 18, 2023 16:46:46 GMT -5
Those $10 Billion insulin behemoths stand to lose a billion a year in market share to us so what’s to stop them spending a hundred mil over the years tossing shares back and forth between houses to stall or kill us? It’s not outrageous to consider. I seriously doubt they see Afrezza as a threat. Last month Afrezza bought in $7.94 Million, Lilly and Novo Nordisk bought in $1.1 Billion on just their old gen RAA insulins. Right now, eight years after launch, Afrezza sells less than the monthly sales fluctuation of either of those two. If you are a big pharma you don't mess with a competitor's stock, that's illegal and leads to bad things for the aggressor. No, you do what UTHR is doing to LQDA - you tie your competitor up in court with worthless suits because that buys you time to have a clear run at the market, this is legal and far more effective. You will know that the big pharmas see Mannkind as a threat when they start filing lawsuits. Yep - if I remember they threw everything they could at MNKD pre-approval and then Pharma Bro showed up. I wonder who paid him and his old boss Jim Cramer? Then I think everyone thought MNKD was going out of business and then Martine throws the lifeline. Afrezza is slowly making progress. Medicare is helping. Its really just a matter of time and IMO BP has not forgotten about afrezza. I still find it interesting Dave Kendall slips out the back jack not long before his old employer comes out with Mounjaro. What exactly will the lawsuits be for? Having the best prandial diabetes solution? We even have Mike now saying the A1c GLP1 reduction period is about 2 years. Finally he is moving forward with the afrezza/GLP1 study. This time last year he didn't want to touch doing that study with a 10ft pole.
|
|
|
Post by prcgorman2 on May 18, 2023 16:55:39 GMT -5
My guess is Shkreli and Cramer made money shorting MNKD. Didn't need to be paid. They just sold borrowed shares. The FDA was complicit (thinking of the 3rd CRL). Might have had something to do with the FDA's executive being married to a hedge fund guy.
|
|
|
Post by sayhey24 on May 18, 2023 17:08:22 GMT -5
My guess is Shkreli and Cramer made money shorting MNKD. Didn't need to be paid. They just sold borrowed shares. The FDA was complicit (thinking of the 3rd CRL). Might have had something to do with the FDA's executive being married to a hedge fund guy. Come on Man! - those guys are not using their own money on a Christmas Day Hail Mary. Granted the Hamburgler's husband was running Renaissance at the time but where were they getting their money? Back in the day Al was showing up on all these morning business TV shows saying how he had the greatest advance in diabetes care and then pulling out the whistle from his pocket and he was glad to see them. It has been bugging me that Mike has not done any of these shows. If he wants to start pumping up the pps that's a good place to start. I guess since until recently he really had no sales plan for afrezza, not doing the shows made sense.
|
|
|
Post by markado on May 18, 2023 21:13:22 GMT -5
Saw on stocktwits someone questioning the "rational case," for shorting MNKD. Then they postulated many elements of the bull case. Absent a rational case, consider the irrational - meaning, the shorts are (anti) competitively motivated, corporately funded, not profit driven, therefore willing to lose 100% of their investment, because they're not playing with their own money, and the goal is not profit but delay and destruction (of value). Just a hypothesis. Those $10 Billion insulin behemoths stand to lose a billion a year in market share to us so what’s to stop them spending a hundred mil over the years tossing shares back and forth between houses to stall or kill us? It’s not outrageous to consider. Exactly.
|
|
|
Post by markado on May 18, 2023 21:29:31 GMT -5
Those $10 Billion insulin behemoths stand to lose a billion a year in market share to us so what’s to stop them spending a hundred mil over the years tossing shares back and forth between houses to stall or kill us? It’s not outrageous to consider. I seriously doubt they see Afrezza as a threat. Last month Afrezza bought in $7.94 Million, Lilly and Novo Nordisk bought in $1.1 Billion on just their old gen RAA insulins. Right now, eight years after launch, Afrezza sells less than the monthly sales fluctuation of either of those two. If you are a big pharma you don't mess with a competitor's stock, that's illegal and leads to bad things for the aggressor. No, you do what UTHR is doing to LQDA - you tie your competitor up in court with worthless suits because that buys you time to have a clear run at the market, this is legal and far more effective. You will know that the big pharmas see Mannkind as a threat when they start filing lawsuits. I don't quite share the opinion that all corporations operate above the law. And, it might not be big pharma insulin companies (alone or at all or directly), how about vial,syringe, and bg strip manufacturers. There are many companies and stakeholders that stand to lose share and value to mnkd. They may be motivated to not make it easy. Otherwise, what maintains to be the rational case for shorting MNKD?
|
|
|
Post by agedhippie on May 18, 2023 21:45:10 GMT -5
What exactly will the lawsuits be for? Having the best prandial diabetes solution? We even have Mike now saying the A1c GLP1 reduction period is about 2 years. Finally he is moving forward with the afrezza/GLP1 study. This time last year he didn't want to touch doing that study with a 10ft pole. What would the lawsuits be for? Patent infringements. Look at UTHR if you want to see how to do this, their play with LQDA was textbook. The patents don't even need to survive review, it's all about sidelining the competition.
|
|